Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-Hematologic Malignancies × figitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 4 Carcinoma, Squamous Cell 3 Sarcoma 2 Prostatic Neoplasms 2 Carcinoma, Large Cell 2 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Recurrence 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Ewing's Sarcoma Family of Tumors 1 Colorectal Neoplasms 1 Carcinoma, Adenosquamous 1 Carcinoma 1 Breast Diseases 1 Advanced Non-Hematologic Malignancies 1 Advanced Cancer 1

Interventions

figitumumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01653158 2013-10-30

CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies

Pfizer

Phase 1 Completed

46 enrolled 34 charts

Advanced Non-Hematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡